ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Immunocore Holdings Plc

Immunocore Holdings Plc is an active company incorporated on 7 January 2021 with the registered office located in Abingdon, Oxfordshire. Immunocore Holdings Plc was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13119746
Public limited company
Age
4 years
Incorporated 7 January 2021
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Over 250 employees
Confirmation
Submitted
Dated 6 January 2025 (9 months ago)
Next confirmation dated 6 January 2026
Due by 20 January 2026 (3 months remaining)
Last change occurred 8 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 June 2026 (8 months remaining)
Address
92 Park Drive
Milton Park
Abingdon
Oxfordshire
OX14 4RY
United Kingdom
Same address for the past 4 years
Telephone
01235 438600
Email
Unreported
People
Officers
11
Shareholders
5
Controllers (PSC)
1
Director • Operating Partner, General Atlantic (Gro • American • Lives in United States • Born in Jul 1964
Director • Physician • American • Lives in United States • Born in Jan 1963
Director • None • American • Lives in United States • Born in Nov 1967
Director • Physician • British,canadian • Lives in UK • Born in Jul 1952
Director • Business Executive • American • Lives in United States • Born in Aug 1959
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
South Lonsdale Investments Limited
Sir Peter John Ratcliffe is a mutual person.
Active
The Wolfson Foundation
Sir Peter John Ratcliffe is a mutual person.
Active
Reox Limited
Sir Peter John Ratcliffe is a mutual person.
Dissolved
Brands
Immunocore Holdings plc
Immunocore Holdings plc is a biotechnology company that has developed a T cell receptor (TCR) therapy.
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£363.26M
Increased by £15.59M (+4%)
Turnover
£242.08M
Increased by £42.17M (+21%)
Employees
500
Increased by 48 (+11%)
Total Assets
£797.32M
Increased by £325.23M (+69%)
Total Liabilities
-£471.84M
Increased by £292.16M (+163%)
Net Assets
£325.48M
Increased by £33.07M (+11%)
Debt Ratio (%)
59%
Increased by 21.12% (+55%)
Latest Activity
Robert Perez Resigned
26 Days Ago on 16 Sep 2025
Group Accounts Submitted
4 Months Ago on 21 May 2025
William Pao Appointed
7 Months Ago on 25 Feb 2025
Confirmation Submitted
8 Months Ago on 20 Jan 2025
Travis Alan Coy Resigned
9 Months Ago on 1 Jan 2025
Charge Satisfied
11 Months Ago on 14 Nov 2024
Ranjeev Krishana Appointed
1 Year 4 Months Ago on 28 May 2024
Group Accounts Submitted
1 Year 5 Months Ago on 18 Apr 2024
Confirmation Submitted
1 Year 7 Months Ago on 23 Feb 2024
Group Accounts Submitted
2 Years 4 Months Ago on 27 May 2023
Get Credit Report
Discover Immunocore Holdings Plc's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 15 September 2025
Submitted on 7 Oct 2025
Termination of appointment of Robert Perez as a director on 16 September 2025
Submitted on 18 Sep 2025
Statement of capital following an allotment of shares on 21 August 2025
Submitted on 8 Sep 2025
Statement of capital following an allotment of shares on 10 July 2025
Submitted on 6 Aug 2025
Statement of capital following an allotment of shares on 16 June 2025
Submitted on 17 Jul 2025
Statement of capital following an allotment of shares on 29 May 2025
Submitted on 18 Jun 2025
Statement of capital following an allotment of shares on 23 April 2025
Submitted on 21 May 2025
Resolutions
Submitted on 21 May 2025
Group of companies' accounts made up to 31 December 2024
Submitted on 21 May 2025
Statement of capital following an allotment of shares on 25 March 2025
Submitted on 25 Apr 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year